Press Releases
All Releases
View Summary Enzon Reports 2nd Quarter 2011 Results
Aug 4, 2011
PDF 53.3 KB Add to Briefcase
View Summary ENZON Names Ana I. Stancic Chief Financial Officer
May 31, 2011
PDF 9.5 KB Add to Briefcase
View Summary Enzon Announces Discontinuation of PEG-SN38 Program in Metastatic Colorectal Carcinoma in Light of Evolving Standards of Care
May 19, 2011
PDF 8.5 KB Add to Briefcase
View Summary Enzon Reports 1st Quarter 2011 Results
May 6, 2011
PDF 62.6 KB Add to Briefcase
View Summary Enzon Presents Data at 2011 AACR Meeting
Apr 5, 2011
PDF 50.3 KB Add to Briefcase
View Summary Enzon Appoints Richard Mulligan, Ph.D. Vice-Chairman of the Board; Adopts Majority Vote Standard for Election of Directors
Mar 17, 2011
PDF 9.4 KB Add to Briefcase
View Summary Enzon Reports 2010 Results
Feb 17, 2011
PDF 74.2 KB Add to Briefcase
View Summary Enzon to Release Fourth Quarter 2010 Earnings on Thursday, February 17, 2011; Conference Call and Webcast to Follow
Feb 10, 2011
PDF 7.0 KB Add to Briefcase
View Summary Enzon to Begin Phase 1 Study of Novel Androgen Receptor mRNA Antagonist in Castration-Resistant Prostate Cancer
Jan 10, 2011
PDF 9.9 KB Add to Briefcase
View Summary Enzon Board Authorizes Share Repurchase Program
Dec 21, 2010
PDF 8.0 KB Add to Briefcase
View Summary Enzon Announces the Initiation of Two Phase I Studies in Collaboration with the National Cancer Institute
Dec 15, 2010
PDF 48.0 KB Add to Briefcase
View Summary Enzon Presents Data at 2010 EORTC-NCI-AACR Meeting
Nov 17, 2010
PDF 49.2 KB Add to Briefcase
View Summary Enzon Reports Third Quarter 2010 Results
Nov 2, 2010
PDF 23.7 KB Add to Briefcase
View Summary Enzon Pharmaceuticals Awarded $1.2 Million in Grants under QTDP Program
Nov 2, 2010
PDF 7.8 KB Add to Briefcase
View Summary CORRECTING and REPLACING Abstracts Highlighting Data from Enzon's mRNA Antagonist Programs Accepted for Presentation at 2010 EORTC-NCI-AACR Meeting
Oct 29, 2010
PDF 9.0 KB Add to Briefcase
View Summary Abstracts Highlighting Data from Enzon's mRNA Antagonist Programs Accepted for Presentation at 2010 EORTC-NCI-AACR Meeting
Oct 29, 2010
PDF 8.6 KB Add to Briefcase
View Summary Enzon to Release Third Quarter 2010 Earnings on Tuesday, November 2, 2010
Oct 26, 2010
PDF 6.7 KB Add to Briefcase
View Summary Enzon Announces Publication of Preclinical Study Data of PEG-SN38 in Pediatric Neuroblastoma
Oct 5, 2010
PDF 12.1 KB Add to Briefcase
View Summary Enzon Reports Second Quarter 2010 Results
Aug 3, 2010
PDF 22.6 KB Add to Briefcase
View Summary Enzon to Release Second Quarter 2010 Earnings on Tuesday, August 3, 2010; Conference Call and Webcast to Follow
Jul 28, 2010
PDF 7.8 KB Add to Briefcase
Showing 21-40 of 331 Page: 1 2 3 4 5 6 ... 17  Previous 20 | Next 20
Add to Briefcase = add release to Briefcase